Cutler Group’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Hold |
0
| – | – | – | 1660 |
|
|
2019
Q4 | – | Sell |
-10
| Closed | -$4K | – | 1731 |
|
|
2019
Q3 | $4K | Buy |
+10
| New | +$4K | ﹤0.01% | 1310 |
|
|
2019
Q2 | – | Sell |
-1
| Closed | -$1K | – | 1814 |
|
|
2019
Q1 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 1415 |
|
|
2018
Q4 | – | Sell |
-30
| Closed | -$43K | – | 1826 |
|
|
2018
Q3 | $43K | Sell |
30
-13
| -30% | -$18.6K | ﹤0.01% | 962 |
|
|
2018
Q2 | $69K | Buy |
43
+29
| +207% | +$46.5K | 0.01% | 811 |
|
|
2018
Q1 | $23K | Buy |
14
+10
| +250% | +$16.4K | ﹤0.01% | 1152 |
|
|
2017
Q4 | $6K | Buy |
4
+1
| +33% | +$1.5K | ﹤0.01% | 1749 |
|
|
2017
Q3 | $4K | Sell |
3
-4
| -57% | -$5.33K | ﹤0.01% | 2161 |
|
|
2017
Q2 | $7K | Buy |
+7
| New | +$7K | ﹤0.01% | 2278 |
|